BLISSGVS:NSE Bliss GVS Pharma Limited

INR 111.80 0.00 0
Icon

Bliss GVS Pharma Limited (BLISSGVS:NSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 111.80

0.00 (0.00)%

INR 11.70B

0.41M

N/A

N/A

Icon

BLISSGVS:NSE

Bliss GVS Pharma Limited (INR)
COMMON STOCK | NSE
INR 111.80
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 11.70B

N/A

INR 111.80

Bliss GVS Pharma Limited (BLISSGVS:NSE) Stock Forecast

N/A

Based on the Bliss GVS Pharma Limited stock forecast from 0 analysts, the average analyst target price for Bliss GVS Pharma Limited is not available over the next 12 months. Bliss GVS Pharma Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bliss GVS Pharma Limited is Slightly Bearish, which is based on 6 positive signals and 8 negative signals. At the last closing, Bliss GVS Pharma Limited’s stock price was INR 111.80. Bliss GVS Pharma Limited’s stock price has changed by -6.52% over the past week, +8.07% over the past month and +50.27% over the last year.

No recent analyst target price found for Bliss GVS Pharma Limited
No recent average analyst rating found for Bliss GVS Pharma Limited

Company Overview Bliss GVS Pharma Limited

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid prepara...Read More

https://www.blissgvs.com

102, Hyde Park, Mumbai, India, 400072

763

March

INR

India

Adjusted Closing Price for Bliss GVS Pharma Limited (BLISSGVS:NSE)

Loading...

Unadjusted Closing Price for Bliss GVS Pharma Limited (BLISSGVS:NSE)

Loading...

Share Trading Volume for Bliss GVS Pharma Limited Shares

Loading...

Compare Performance of Bliss GVS Pharma Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BLISSGVS:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bliss GVS Pharma Limited (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SUNPHARMA:NSE
Sun Pharmaceutical Industries .. 0.00 (0.00%) INR3,888.23B 43.73 28.09

ETFs Containing BLISSGVS

Symbol Name BLISSGVS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bliss GVS Pharma Limited (BLISSGVS:NSE) Stock

Stock Target Advisor's fundamental analysis for Bliss GVS Pharma Limited's stock is Slightly Bearish.

BLISSGVS:NSE stock's dividend yield is 0.45%. Our analysis grades BLISSGVS:NSE stock's dividend yield at F. This means that BLISSGVS:NSE stock's dividend yield is above 43% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this BLISSGVS:NSE may be a average dividend stock for its sector.

Unfortunately we do not have enough data on BLISSGVS:NSE's stock to indicate what its average analyst target is.

BLISSGVS:NSE stock's Price/Earning ratio is 13.47. Our analysis grades BLISSGVS:NSE stock's Price / Earning ratio at B+. This means that BLISSGVS:NSE stock's Price/Earning ratio is above 11% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this BLISSGVS:NSE may be undervalued for its sector.

The last closing price of BLISSGVS:NSE's stock was INR 111.80.

The most recent market capitalization for BLISSGVS:NSE is INR 11.70B.

Unfortunately we do not have enough analyst data on BLISSGVS:NSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bliss GVS Pharma Limited's stock.

As per our most recent records Bliss GVS Pharma Limited has 763 Employees.

Bliss GVS Pharma Limited's registered address is 102, Hyde Park, Mumbai, India, 400072. You can get more information about it from Bliss GVS Pharma Limited's website at https://www.blissgvs.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...